1
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
Condition(s):Age Related Macular Degeneration; Geographic Atrophy; AMD; Age-related Macular DegenerationLast Updated:February 4, 2021Recruiting
Age-related Macular Degeneration: 1920 Clinical Trials, Page 1 of 192
Hide Studies Not Open or Pending
2
Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
Condition(s):Age Related Macular DegenerationLast Updated:July 13, 2020Terminated
3
Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator
Condition(s):Age-related Macular DegenerationLast Updated:June 6, 2019Completed
4
Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)
Condition(s):Age-related Macular DegenerationLast Updated:September 17, 2020Active, not recruiting
5
Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:January 5, 2021Completed
6
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells
Condition(s):Dry Age-related Macular DegenerationLast Updated:January 31, 2018Unknown status
7
Medico-economic Evaluation of Anti-VEGF Treatments in the Treatment of naïve Age-related Macular Degeneration (AMD): a Model Adapted to the French Context
Condition(s):Age-related Macular Degeneration (AMD)Last Updated:February 4, 2019Unknown status
8
Study of the Discriminating Power of a Blood Biomarker for Omega-3 Polyunsaturated Fatty Acid Content of the Retina for Age-related Macular Degeneration (AMD)
Condition(s):Age-related Macular DegenerationLast Updated:November 24, 2020Completed
9
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Condition(s):Advanced Age-related Macular DegenerationLast Updated:May 1, 2012Completed
10
UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)
Condition(s):Neovacular Age-related Macular DegenerationLast Updated:May 3, 2017Completed